Skip to main content

Closed

MBRX: Moleculin Biotech, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-173.9%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio1.38×

Moleculin Biotech, Inc.

MBRXNASDAQ Capital Market·USD·Closed

Moleculin Biotech, Inc.

MBRXNASDAQ·USD·Closed

$0.40

−60.78%

$0.40

−$0.62 (60.78%)

52W Range

0thpctl

Volume

35.47×avg

Mkt Cap

2.13MUSD

P/E

-0.0TTM

Div Yield

–ann

52W Range

0thpctl

Volume

35.47×avg

Market Cap

2.13MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings